Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 122.34 | 58.48 | 36.98 | 28.27 |
Total Revenue | 122.34 | 58.48 | 36.98 | 28.27 |
Costof Revenue Total | 110.68 | 53.34 | 34.69 | 26.56 |
Gross Profit | 11.66 | 5.14 | 2.29 | 1.71 |
Selling/ General/ Admin Expenses Total | 3.51 | 1.10 | 0.62 | 0.54 |
Depreciation/ Amortization | 0.12 | 0.10 | 0.11 | 0.13 |
Unusual Expense( Income) | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Expenses Total | 1.82 | 1.07 | 0.39 | 0.32 |
Total Operating Expense | 116.13 | 55.61 | 35.81 | 27.55 |
Operating Income | 6.21 | 2.86 | 1.17 | 0.72 |
Interest Inc( Exp) Net- Non- Op Total | -2.85 | -1.22 | -0.65 | -0.64 |
Other Net | -0.14 | 0.03 | 0.03 | 0.10 |
Net Income Before Taxes | 3.23 | 1.68 | 0.55 | 0.17 |
Provisionfor Income Taxes | 0.77 | 0.44 | 0.20 | 0.07 |
Net Income After Taxes | 2.46 | 1.23 | 0.35 | 0.10 |
Minority Interest | -0.02 | 0.00 | 0.00 | 0.00 |
Net Income Before Extra Items | 2.44 | 1.23 | 0.35 | 0.10 |
Net Income | 2.44 | 1.23 | 0.35 | 0.10 |
Total Adjustmentsto Net Income | 0.00 | - | - | - |
Income Availableto Com Excl Extra Ord | 2.44 | 1.23 | 0.35 | 0.10 |
Income Availableto Com Incl Extra Ord | 2.44 | 1.23 | 0.35 | 0.10 |
Diluted Net Income | 2.44 | 1.23 | 0.35 | 0.10 |
Diluted Weighted Average Shares | 1.54 | 1.77 | 1.77 | 1.77 |
Diluted EPS Excluding Extra Ord Items | 1.59 | 0.70 | 0.20 | 0.05 |
Diluted Normalized EPS | 1.59 | 0.70 | 0.20 | 0.05 |
period Length | 12.00 | 12.00 | 12.00 | 12.00 |
period Type | - | - | - | - |
Mono Pharmacare Dividend Mono Pharmacare Bonus Mono Pharmacare News Mono Pharmacare AGM Mono Pharmacare Rights Mono Pharmacare Splits Mono Pharmacare Board Meetings Mono Pharmacare Key Metrics Mono Pharmacare Shareholdings Mono Pharmacare Balance Sheet Mono Pharmacare Cashflow Mono Pharmacare Q1 Results Mono Pharmacare Q2 Results Mono Pharmacare Q3 Results Mono Pharmacare Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks